Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing-Reference-Cited by-同舟云学术

Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing

Published:2015-04-30 Issue:4 Volume:10 Page:e0125571
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yang Xiaochen,Wu Jiong,Lu Jingsong,Liu Guangyu,Di Genhong,Chen Canming,Hou Yifeng,Sun Menghong,Yang Wentao,Xu Xiaojing,Zhao Ying,Hu Xin,Li Daqiang,Cao Zhigang,Zhou Xiaoyan,Huang Xiaoyan,Liu Zhebin,Chen Huan,Gu Yanzi,Chi Yayun,Yan Xia,Han Qixia,Shen Zhenzhou,Shao Zhimin,Hu Zhen

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality;SM Domchek;JAMA,2010

2. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations;KD Gonzalez;J Clin Oncol,2009

3. Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer;MG FitzGerald;Oncogene,1998

4. Hereditary diffuse gastric cancer: association with lobular breast cancer;KA Schrader;Fam Cancer,2008

5. Ten genes for inherited breast cancer;T Walsh;Cancer Cell,2007

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel;PLOS ONE;2023-09-01

2. Using species richness calculations to model the global profile of unsampled pathogenic variants: Examples from BRCA1 and BRCA2;PLOS ONE;2023-02-08

3. N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis;Cell Chemical Biology;2023-02

4. Genetic Predisposition to Male Breast Cancer: A Case Series;Anticancer Research;2022-12

5. Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors;Frontiers in Oncology;2022-06-17